Trials / Completed
CompletedNCT01068158
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
A Double-Blind Randomized Study to Compare the Efficacy, Safety, and Local Tolerability of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 371 (actual)
- Sponsor
- Topaz Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 5 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.5% Ivermectin Cream | Up to 4 ounces of 0.5% Ivermectin Cream applied to hair and scalp on day 1. |
| DRUG | Placebo control | up to 4 ounces of topical vehicle control to head and scalp on day 1. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-06-01
- Completion
- 2010-07-01
- First posted
- 2010-02-12
- Last updated
- 2012-04-06
- Results posted
- 2012-04-04
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01068158. Inclusion in this directory is not an endorsement.